Core Points - Indaptus Therapeutics, Inc. has entered into securities purchase agreements for a private placement of 2,109,383 shares of common stock and accompanying warrants [1][3] - The effective purchase price for each share and associated warrants is 2.25 million [1][3] - The warrants will have an exercise price of $0.94 per share, are immediately exercisable, and have a term of five years [2] Financial Details - The net proceeds from the offering will be used to fund research and development activities, working capital, and general corporate purposes [3] - The offering is expected to close on or about January 15, 2025, subject to customary closing conditions [1] Regulatory Information - The shares and warrants are offered in a private placement under Section 4(a)(2) of the Securities Act of 1933 and/or Rule 506(b) of Regulation D [4] - The securities have not been registered under the Securities Act and may not be reoffered or resold in the U.S. without an effective registration statement or applicable exemption [4]
Indaptus Therapeutics, Inc. Announces $2.25 Million Private Placement Priced At-The-Market Under Nasdaq Rules